Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy.

M. Witsch-Baumgartner, P. Clayton, N. Clusellas, D. Haas, R. I. Kelley, M. Krajewska-Walasek, S. Lechner, M. Rossi, J. Zschocke, G. Utermann

Research output: Contribution to journalArticle

Abstract

The Smith-Lemli-Opitz syndrome (SLOS) is a phenotypically variable metabolic malformation and mental retardation syndrome for which more than 80 mutations in the DHCR7 disease-causing gene have been described. The DHCR7 mutational spectra differ significantly in different areas of Europe, and several common putative founder mutations account for a substantial fraction of all mutations in some ethnic groups. Here we have analysed 47 SLOS patients and describe 14 newly identified mutations in 18 SLOS patients of Ashkenazi Jewish, Austrian, British, German, Italian, Irish, Polish, Portuguese, and Spanish origins. Half of the new mutations are in the transmembrane domains of the protein. In addition, there were two null mutations, one mutation in the 4th cytoplasmic loop, two mutations in the first and last codons, and three mutations in other regions such as the second cytoplasmic loop and the first endoplasmic loop. The analysis included 20 Spanish and 12 Italian SLOS patients and revealed very different mutation spectra in these patients compared to previously described patients from Czechoslovakia, Germany, Poland, and the UK and implicated p.Thr93Met on the J haplotype as the most frequent Mediterranean founder mutation.

Original languageEnglish (US)
Pages (from-to)412
Number of pages1
JournalHuman Mutation
Volume25
Issue number4
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Smith-Lemli-Opitz Syndrome
Spain
Italy
Mutation
Czechoslovakia
Poland
Ethnic Groups
Codon
Intellectual Disability
Haplotypes
Germany

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Witsch-Baumgartner, M., Clayton, P., Clusellas, N., Haas, D., Kelley, R. I., Krajewska-Walasek, M., ... Utermann, G. (2005). Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Human Mutation, 25(4), 412.

Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. / Witsch-Baumgartner, M.; Clayton, P.; Clusellas, N.; Haas, D.; Kelley, R. I.; Krajewska-Walasek, M.; Lechner, S.; Rossi, M.; Zschocke, J.; Utermann, G.

In: Human Mutation, Vol. 25, No. 4, 04.2005, p. 412.

Research output: Contribution to journalArticle

Witsch-Baumgartner, M, Clayton, P, Clusellas, N, Haas, D, Kelley, RI, Krajewska-Walasek, M, Lechner, S, Rossi, M, Zschocke, J & Utermann, G 2005, 'Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy.', Human Mutation, vol. 25, no. 4, pp. 412.
Witsch-Baumgartner M, Clayton P, Clusellas N, Haas D, Kelley RI, Krajewska-Walasek M et al. Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Human Mutation. 2005 Apr;25(4):412.
Witsch-Baumgartner, M. ; Clayton, P. ; Clusellas, N. ; Haas, D. ; Kelley, R. I. ; Krajewska-Walasek, M. ; Lechner, S. ; Rossi, M. ; Zschocke, J. ; Utermann, G. / Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. In: Human Mutation. 2005 ; Vol. 25, No. 4. pp. 412.
@article{12e54184fd66450d9064c53245f9c3a6,
title = "Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy.",
abstract = "The Smith-Lemli-Opitz syndrome (SLOS) is a phenotypically variable metabolic malformation and mental retardation syndrome for which more than 80 mutations in the DHCR7 disease-causing gene have been described. The DHCR7 mutational spectra differ significantly in different areas of Europe, and several common putative founder mutations account for a substantial fraction of all mutations in some ethnic groups. Here we have analysed 47 SLOS patients and describe 14 newly identified mutations in 18 SLOS patients of Ashkenazi Jewish, Austrian, British, German, Italian, Irish, Polish, Portuguese, and Spanish origins. Half of the new mutations are in the transmembrane domains of the protein. In addition, there were two null mutations, one mutation in the 4th cytoplasmic loop, two mutations in the first and last codons, and three mutations in other regions such as the second cytoplasmic loop and the first endoplasmic loop. The analysis included 20 Spanish and 12 Italian SLOS patients and revealed very different mutation spectra in these patients compared to previously described patients from Czechoslovakia, Germany, Poland, and the UK and implicated p.Thr93Met on the J haplotype as the most frequent Mediterranean founder mutation.",
author = "M. Witsch-Baumgartner and P. Clayton and N. Clusellas and D. Haas and Kelley, {R. I.} and M. Krajewska-Walasek and S. Lechner and M. Rossi and J. Zschocke and G. Utermann",
year = "2005",
month = "4",
language = "English (US)",
volume = "25",
pages = "412",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy.

AU - Witsch-Baumgartner, M.

AU - Clayton, P.

AU - Clusellas, N.

AU - Haas, D.

AU - Kelley, R. I.

AU - Krajewska-Walasek, M.

AU - Lechner, S.

AU - Rossi, M.

AU - Zschocke, J.

AU - Utermann, G.

PY - 2005/4

Y1 - 2005/4

N2 - The Smith-Lemli-Opitz syndrome (SLOS) is a phenotypically variable metabolic malformation and mental retardation syndrome for which more than 80 mutations in the DHCR7 disease-causing gene have been described. The DHCR7 mutational spectra differ significantly in different areas of Europe, and several common putative founder mutations account for a substantial fraction of all mutations in some ethnic groups. Here we have analysed 47 SLOS patients and describe 14 newly identified mutations in 18 SLOS patients of Ashkenazi Jewish, Austrian, British, German, Italian, Irish, Polish, Portuguese, and Spanish origins. Half of the new mutations are in the transmembrane domains of the protein. In addition, there were two null mutations, one mutation in the 4th cytoplasmic loop, two mutations in the first and last codons, and three mutations in other regions such as the second cytoplasmic loop and the first endoplasmic loop. The analysis included 20 Spanish and 12 Italian SLOS patients and revealed very different mutation spectra in these patients compared to previously described patients from Czechoslovakia, Germany, Poland, and the UK and implicated p.Thr93Met on the J haplotype as the most frequent Mediterranean founder mutation.

AB - The Smith-Lemli-Opitz syndrome (SLOS) is a phenotypically variable metabolic malformation and mental retardation syndrome for which more than 80 mutations in the DHCR7 disease-causing gene have been described. The DHCR7 mutational spectra differ significantly in different areas of Europe, and several common putative founder mutations account for a substantial fraction of all mutations in some ethnic groups. Here we have analysed 47 SLOS patients and describe 14 newly identified mutations in 18 SLOS patients of Ashkenazi Jewish, Austrian, British, German, Italian, Irish, Polish, Portuguese, and Spanish origins. Half of the new mutations are in the transmembrane domains of the protein. In addition, there were two null mutations, one mutation in the 4th cytoplasmic loop, two mutations in the first and last codons, and three mutations in other regions such as the second cytoplasmic loop and the first endoplasmic loop. The analysis included 20 Spanish and 12 Italian SLOS patients and revealed very different mutation spectra in these patients compared to previously described patients from Czechoslovakia, Germany, Poland, and the UK and implicated p.Thr93Met on the J haplotype as the most frequent Mediterranean founder mutation.

UR - http://www.scopus.com/inward/record.url?scp=23944498167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944498167&partnerID=8YFLogxK

M3 - Article

C2 - 15776424

AN - SCOPUS:23944498167

VL - 25

SP - 412

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -